Quetiapine in Co-Morbid Depressive and Anxiety Disorders
Status:
Completed
Trial end date:
2013-06-01
Target enrollment:
Participant gender:
Summary
This multi-centred study will be conducted at three centres. The design will be a randomized,
placebo-controlled, parallel-group one. This investigation will evaluate the efficacy of
add-on Quetiapine XR (extended release) treatment for patients who meet diagnostic criteria
for depressive disorders and one or more comorbid anxiety disorder.